JPMorgan Starts ADARx Pharmaceuticals (ADRX) at Overweight Oct 20, 2026 05:10AM
Morgan Stanley Starts ADARx Pharmaceuticals (ADRX) at Overweight Oct 20, 2026 03:50AM
UBS Starts ADARx Pharmaceuticals (ADRX) at Buy Oct 20, 2026 03:40AM
TD Cowen Starts ADARx Pharmaceuticals (ADRX) at Buy Oct 20, 2026 03:03AM
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors Sep 25, 2026 10:34AM


Sep 25, 2026 10:31AM ADARx Pharmaceuticals indicated to open at $28, IPO priced at $17
Sep 21, 2026 06:45AM ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO
Sep 21, 2026 06:11AM ADARx Pharmaceuticals (ADRX) files for 21.875M share IPO at $15-$17/sh
Sep 14, 2026 05:04PM ADARx Pharmaceuticals (ADRX) files for Nasdaq IPO
Sep 4, 2026 05:28PM ADARx Pharmaceuticals files for proposed IPO